1. A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics. (21st February 2022) Authors: Zhudenkov, Kirill; Gavrilov, Sergey; Sofronova, Alina; Stepanov, Oleg; Kudryashova, Nataliya; Helmlinger, Gabriel; Peskov, Kirill Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 4(2022) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors. Issue 12 (9th September 2019) Authors: Yakovleva, Tatiana; Sokolov, Victor; Chu, Lulu; Tang, Weifeng; Greasley, Peter J.; Peilot Sjögren, Helena; Johansson, Susanne; Peskov, Kirill; Helmlinger, Gabriel; Boulton, David W.; Penland, Robert C. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 12(2019) Page Start: 2684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling. (6th March 2020) Authors: Sokolov, Victor; Yakovleva, Tatiana; Chu, Lulu; Tang, Weifeng; Greasley, Peter J.; Johansson, Susanne; Peskov, Kirill; Helmlinger, Gabriel; Boulton, David W.; Penland, Robert C. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 9:Number 4(2020) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis. (1st January 2020) Authors: Shulgin, Boris; Kosinsky, Yuri; Omelchenko, Andrey; Chu, Lulu; Mugundu, Ganesh; Aksenov, Sergey; Pimentel, Rodrigo; DeYulia, Garrett; Kim, Geoffrey; Peskov, Kirill; Helmlinger, Gabriel Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis. (1st January 2020) Authors: Shulgin, Boris; Kosinsky, Yuri; Omelchenko, Andrey; Chu, Lulu; Mugundu, Ganesh; Aksenov, Sergey; Pimentel, Rodrigo; DeYulia, Garrett; Kim, Geoffrey; Peskov, Kirill; Helmlinger, Gabriel Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exenatide effects on gastric emptying rate and the glucose rate of appearance in plasma: A quantitative assessment using an integrative systems pharmacology model. Issue 8 (9th May 2018) Authors: Voronova, Veronika; Zhudenkov, Kirill; Penland, Robert C.; Boulton, David W.; Helmlinger, Gabriel; Peskov, Kirill Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 8(2018) Page Start: 2034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Integrating dose estimation into a decision‐making framework for model‐based drug development. (10th January 2018) Authors: Dunyak, James; Mitchell, Patrick; Hamrén, Bengt; Helmlinger, Gabriel; Matcham, James; Stanski, Donald; Al‐Huniti, Nidal Journal: Pharmaceutical statistics Issue: Volume 17:Number 2(2018) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Longitudinal Tumor Size and Neutrophil‐to‐Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Durvalumab. (21st December 2020) Authors: Gavrilov, Sergey; Zhudenkov, Kirill; Helmlinger, Gabriel; Dunyak, James; Peskov, Kirill; Aksenov, Sergey Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 1(2021) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Longitudinal Tumor Size and Neutrophil‐to‐Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Durvalumab. (21st December 2020) Authors: Gavrilov, Sergey; Zhudenkov, Kirill; Helmlinger, Gabriel; Dunyak, James; Peskov, Kirill; Aksenov, Sergey Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 1(2021) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal Dysfunction. (6th November 2017) Authors: Gebremichael, Yeshitila; Lu, James; Shankaran, Harish; Helmlinger, Gabriel; Mettetal, Jerome; Hallow, K Melissa Journal: Toxicological sciences Issue: Volume 162:Number 1(2018) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗